MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Country |
 USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.48 B |
Market Cap[1] |
$ 110 B |
EBITDA (LTM) |
$ 4.18 B |
P/E (LTM) |
40.45 |
P/S (LTM) |
5.77 |
EPS (LTM) |
1.83 |
Boston Scientific is an international company that specializes in the development and manufacturing of medical devices and technologies for the treatment of various diseases. It was founded in 1979 in the United States and is now one of the largest medical device manufacturers in the world.
Boston Scientific offers a wide range of medical devices, including stents, cardiac pacemakers, defibrillators, electrodes, urological and gynecological devices, and much more. It also provides physician training, consultation, and patient support services.
The company has offices around the world and serves patients in over 100 countries. Its headquarters are located in Massachusetts, USA.
The goal of Boston Scientific is to help people live healthy lives by providing them with innovative medical devices and technologies. The company actively works on developing new products and improving the quality of its services to meet the needs of its customers.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | USA |
 |
LivaNova PLC
LIVN
|
$ 69.84 | 1.14 % | $ 3.79 B | Nasdaq Global Select Market |  Britain |
 |
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Cognyte Software Ltd.
CGNT
|
$ 6.61 | 3.44 % | $ 475 M | Nasdaq Global Select Market,SPB |  Israel |
 |
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | USA |
 |
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market |  China |
 |
Alphatec Holdings
ATEC
|
$ 13.85 | -0.57 % | $ 2.08 B | Nasdaq Global Select Market | USA |
 |
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | USA |
 |
AxoGen
AXGN
|
$ 31.25 | -3.85 % | $ 1.44 B | Nasdaq Capital Market,SPB | USA |
 |
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | USA |
 |
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | USA |
 |
Apyx Medical Corporation
APYX
|
$ 3.46 | -2.26 % | $ 120 M | Nasdaq Global Select Market | USA |
 |
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | USA |
 |
Bio-Rad Laboratories
BIO
|
$ 269.55 | 0.25 % | $ 7.61 B | NYSE,SPB | USA |
 |
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | USA |
 |
EDAP TMS S.A.
EDAP
|
$ 4.63 | 3.58 % | $ 173 M | Nasdaq Global Market |  France |
 |
Bruker Corporation
BRKR
|
$ 39.92 | 0.38 % | $ 5.95 K | Nasdaq Global Select Market,SPB | USA |
 |
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | USA |
 |
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | USA |
 |
ClearPoint Neuro
CLPT
|
$ 15.18 | 4.3 % | $ 410 M | Nasdaq Capital Market | USA |
 |
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | USA |
 |
CONMED Corporation
CNMD
|
$ 46.01 | -0.07 % | $ 1.43 B | NYSE,SPB | USA |
 |
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | USA |
 |
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | USA |
 |
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | Israel |
 |
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | USA |
 |
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market |  Canada |
 |
InMode Ltd.
INMD
|
$ 13.96 | -0.14 % | $ 902 M | Nasdaq Global Select Market,SPB | Israel |
 |
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | USA |
 |
Delcath Systems
DCTH
|
$ 10.16 | 2.11 % | $ 290 M | Nasdaq Capital Market | USA |
 |
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | USA |
 |
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | USA |
 |
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | USA |
 |
Electromed
ELMD
|
$ 23.53 | 1.64 % | $ 199 M | NYSE American | USA |
 |
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | USA |
 |
Establishment Labs Holdings
ESTA
|
$ 77.39 | -2.87 % | $ 2.18 B | Nasdaq Capital Market |  Costa-rica |
 |
Nano-X Imaging Ltd.
NNOX
|
$ 2.46 | 1.23 % | $ 144 M | Nasdaq Global Select Market | Israel |
 |
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | USA |
 |
FONAR Corporation
FONR
|
$ 18.54 | -0.16 % | $ 122 M | Nasdaq Capital Market | USA |
 |
Globus Medical
GMED
|
$ 95.57 | 3.99 % | $ 12.9 B | NYSE,SPB | USA |
 |
Profound Medical Corp.
PROF
|
$ 7.35 | 2.79 % | $ 180 M | Nasdaq Global Select Market | Canada |
 |
Helius Medical Technologies
HSDT
|
$ 2.18 | 17.84 % | $ 1.33 M | Nasdaq Capital Market | USA |
 |
IRadimed Corporation
IRMD
|
$ 100.38 | 1.3 % | $ 1.27 B | Nasdaq Global Select Market | USA |
 |
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
$ 11.54 | 0.09 % | $ 889 M | Nasdaq Global Select Market,SPB | USA |
 |
Inogen
INGN
|
$ 6.07 | 3.94 % | $ 144 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.